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Background and Purpose—White matter hyperintensities (WMH) on MRI are a quantitative marker for sporadic cerebral 
small vessel disease and are highly heritable. To date, large-scale genetic studies have identified only a single locus 
influencing WMH burden. This might in part relate to biological heterogeneity of sporadic WMH. The current study 
searched for genetic modifiers of WMH volume in cerebral autosomal-dominant arteriopathy with subcortical infarcts 
and leukoencephalopathy (CADASIL), a monogenic small vessel disease.
Methods—We performed a genome-wide association study to identify quantitative trait loci for WMH volume by 
combining data from 517 CADASIL patients collected through 7 centers across Europe. WMH volumes were centrally 
analyzed and quantified on fluid attenuated inversion recovery images. Genotyping was performed using the Affymetrix 
6.0 platform. Individuals were assigned to 2 distinct genetic clusters (cluster 1 and cluster 2) based on their genetic 
background.
Results—Four hundred sixty-six patients entered the final genome-wide association study analysis. The phenotypic variance 
of WMH burden in CADASIL explained by all single nucleotide polymorphisms in cluster 1 was 0.85 (SE=0.21), 
suggesting a substantial genetic contribution. Using cluster 1 as derivation and cluster 2 as a validation sample, a polygenic 
score was significantly associated with WMH burden (P=0.001) after correction for age, sex, and vascular risk factors. No 
single nucleotide polymorphism reached genome-wide significance.
Conclusions—We found a polygenic score to be associated with WMH volume in CADASIL subjects. Our findings suggest 
that multiple variants with small effects influence WMH burden in CADASIL. The identification of these variants and 
the biological pathways involved will provide insights into the pathophysiology of white matter disease in CADASIL and 
possibly small vessel disease in general.   (Stroke. 2014;45:968-972.)
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Radiographic white matter lesions, visible on T2-weighted and fluid attenuated inversion recovery (FLAIR) MRI as 
signal hyperintensities, are the most common manifestation 
of cerebrovascular disease in elderly persons.1 In population-
based surveys of individuals >50 years of age, well over two 
thirds have some degree of white matter hyperintensities 
(WMH), and their prevalence substantially increases with 
age.2–4 Because radiographic WMH predict the risk of stroke, 
cognitive decline,  late-life depression, and deterioration of 
gait,1 preventing WMH progression holds the promise of 
markedly reducing  age-related disability.
Twin, sibling, and family history studies have demonstrated 
a strong genetic contribution to WMH. Previous reports have 
estimated that between 50% and 70% of interindividual dif-
ferences in WMH volumes result from differences in genetic 
background.3,5,6 However, specific genetic variants or chro-
mosomal regions underlying this variability are still largely 
unknown. Most genetic studies conducted previously offered 
limited insights on individual genes.3,7,8 In contrast, a recent 
report using genome-wide approaches provided evidence for 
an association between a locus on chromosome 17q25 and 
WMH burden, which was subsequently replicated in an inde-
pendent study.9,10
The identification of genetic determinants accounting for 
the high degree of heritability of WMH has been challeng-
ing, despite large sample sizes available for study. A presumed 
explanation has been heterogeneity within study samples and 
frequent coexistence of age-related pathologies and vascular 
risk factors. Cerebral autosomal-dominant arteriopathy with 
subcortical infarcts and leukoencephalopathy (CADASIL), a 
hereditary small vessel disease (SVD) caused by mutations in 
NOTCH3, may offer a unique opportunity to identify genetic 
determinants of WMH11 because of its relative homogeneity. 
WMH volumes in CADASIL show a striking variability that 
is not related to different mutations described at the NOTCH3 
locus or to demographic factors (Figure 1). Instead, previ-
ous data suggest a strong influence of genetic modifiers12 on 
CADASIL-related WMH.
The aim of the current study, therefore, was to perform a 
genome-wide search for common genetic variants that may 
modify WMH volume in CADASIL with the hope of identify-
ing the loci that may play a role in sporadic SVD as well. This 
was done by combining data from 517 CADASIL patients 
recruited through 7 centers across Europe.
Materials and Methods
Consortium Organization and Study Sample
The CADASIL GWAS (genome-wide association study) consortium 
is an academic collaboration aiming to identify genetic modifiers of 
radiographic and clinical features in CADASIL patients with the pri-
mary objective to identify quantitative trait loci for WMH volume. 
Patients were recruited through 7 sites across Europe (Florence, 
Leiden, London, Siena, Ascoli, Paris, and Munich; Figure 2). 
Inclusion criteria were: (1) a diagnosis of CADASIL documented by 
mutational analysis of the NOTCH3 gene or skin biopsy; (2) electron-
ic MRI data with at least FLAIR-weighted imaging; and (3) availabil-
ity of demographic and clinical information including vascular risk 
factor profiles. The study protocol was approved by the ethics com-
mittee of the coordinating site. In addition, each site had institutional 
review board approval of its consent procedures, cohort examination, 
and surveillance. All participants of the study gave informed consent 
for study participation, MRI scanning, and use of DNA.
Hypertension was defined as antihypertensive treatment or 
systolic blood pressure >140 mm Hg or diastolic >90 mm Hg. 
Hypercholesterolemia was defined as lipid-lowering treatment or el-
evated serum cholesterol (>5.2 mmol/L). Smoking was determined 
by pack-years (packs of cigarettes per day×years). Diabetes mellitus 
was defined as any previous diagnosis of diabetes mellitus.
MRI Scans and WMH Quantification
At each site, standardized MRI scans were performed using scan-
ners operating at field strengths between 0.5 and 3 Tesla. Scans 
were electronically transferred to BioClinica Inc (Lyon, France) for 
quality checks and processing. WMH volumes were measured on 
FLAIR MR scans using a semiautomated method and custom 2-di-
mensional and 3-dimensional editing tools from BioClinica as de-
scribed previously.13 All hyperintense subcortical lesions on FLAIR 
images (regardless of whether they occurred in white or subcortical 
grey matter) were labeled WMH. Segmentations were checked and 
corrected by trained raters (neurologists and neuroscientists with >5 
years of experience with SVD-related lesions). Intracranial cavity 
was assessed from T2- or proton density–weighted images using an 
automated  3-dimensional image segmentation algorithm followed 
by manual correction. WMH volumes were divided by intracranial 
cavity volume to normalize for head size. All raters were blinded 
with regard to clinical and demographic data. Interrater reliability 
for normalized WMH volume was very high, with an intraclass cor-
relation coefficient of 0.996.
Genotyping and Statistical Analysis
CADASIL cases were genotyped at the Helmholtz Center (Munich, 
Germany) and the Broad Institute (Cambridge, MA) using the 
Affymetrix 6.0 platform. Rigorous quality control analyses were per-
formed. Samples with low call rate (<0.96), excess autosomal hetero-
zygosity (false discovery rate >0.05), or close family relationships 
characterized by a high identity-by-state (>0.95) were excluded. In 
total, 487 samples passed quality controls. Identity-by-state–based 
principal component analysis was performed to identify clusters 
of samples that differ in genetic background. Two main clusters 
emerged (Figure in the online-only Data Supplement): the first clus-
ter (n=339) consisted of samples mostly from London, Munich, and 
Leiden, whereas the second cluster (n=127) included samples from 
Ascoli, Florence, and Siena. The Paris sample was represented in 
both clusters. For both clusters, we used marker inclusion thresholds 
of minor allele frequency >0.01, single nucleotide polymorphism 
(SNP) call rate >0.9, and deviation from Hardy–Weinberg equilib-
rium P>0.0001. This yielded 650 006 autosomal SNPs in cluster 1 
and 583 499 autosomal SNPs in cluster 2. Eighteen individuals were 
identified as outliers (Figure in the online-only Data Supplement) and 
were thus excluded. In total, 466 patients were available with high-
quality genotyping data.
GWAS analyses were conducted with the GenABEL package 
for R14 under an additive model and correction for age, sex, and 
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Figure 1. Variability of white matter hyperintensity (WMH) volume 
in cerebral autosomal-dominant arteriopathy with subcortical 
infarcts and leukoencephalopathy. Three patients carrying the 
same (R1006C) NOTCH3 mutation show striking differences in 
WMH volumes. FLAIR indicates fluid attenuated inversion recov-
ery; and nWMHV, normalized WMH volume.
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hypertension. The mmscore function within GenABEL was used to 
implement a powerful family-based association test with control for 
stratification in admixed samples by providing the estimates of an-
cestry of each individual as covariates.14 Results were corrected for 
possible genomic inflation. We used GWAMA15 for meta-analysis 
of summary statistics generated from GWAS of quantitative traits. 
Genomic control of summary statistics was performed to correct for 
population structure within each study and potential variation be-
tween studies. Results from the analyses of both clusters were meta-
analyzed using an inverse-variance fixed-effects approach to form 
the final result.
Heritability Calculation
Heritability was approximated by the phenotypic variance of WMH 
explained by autosomal SNPs using the GCTA software package.16 
In a strict sense, only the proportion of phenotypic variance (Vg/Vp) 
attributable to the variation in genotyped SNPs is measured, where 
Vg is the component of phenotypic variance attributable to the vari-
ation in genotyped SNPs, and Vp is the total observed phenotypic 
variance. To account for population substructure, heritability was 
calculated solely within the largest cluster 1. A linear mixed mod-
el was used to estimate the contribution of genotyped SNPs (and 
causal variants in linkage disequilibrium with genotyped SNPs) to 
the variance in phenotype. Age, sex, hypertension, and eigenvec-
tors from 20 principal components of the population structure were 
used as covariates.
Polygenic Model
To estimate the association of WMH burden with the combined 
effects of multiple genetic variants of very small effect, we used 
a polygenic score analysis.17 Polygenic scores were derived in 
PLINK18 by using all SNPs passing nominal significance thresholds 
(P threshold=1e−4, 0.001, 0.01, 0.1, 0.5) in cluster 1 as a derivation 
cohort to calculate the weighted allele dosages in cluster 2 as a vali-
dation cohort. For this analysis, a pruned subset of approximately 
independent autosomal SNPs (maximum pairwise r2=0.25 within 
sliding windows of 100 SNPs) was used. The associations between 
WMH volume and polygenic scores adjusted for age, sex, and hy-
pertension as covariates were calculated by computing an ANOVA 
table for 2 linear model fits: a full model including the intercept, the 
polygenic score, and all covariates; and a reduced model that only 
included the intercept and covariates. The analysis was performed 
using R  (http://www.R-project.org). Adjusted R2 for the full and re-
duced models was used as a measure to describe the explained vari-
ance in WMH volume.
Results
A total of 466 patients entered the final GWAS analysis 
(Table 1). There was no evidence for genomic inflation within 
cluster 1 and cluster 2 (data not shown) or in the  meta-analysis. 
Figure 3 shows the genome-wide plot of P values for individual 
SNPs against their genomic position adjusted for age, sex, and 
Figure 2. Study profile. Schematic representation 
of patient recruitment, MR quantification, and geno-
typing. GWAS indicates genome-wide association 
study; and QC, quality control. 
Table 1. Clinical Characteristics of Individuals With CADASIL Included Into the Final Genome-Wide Association Analysis
Florence (n=27) Leiden (n=29) London (n=69) Siena (n=21) Ascoli (n=57) Paris (n=173) Munich (n=90) Total (n=466)
Demographics
  Age, y (median;  
IQR; range)
51 (29.2; 22–78) 53 (12; 28–67) 49 (15; 19–69) 48 (15; 31–74) 58.5 (18.75; 31–83) 51 (15.2; 24–74) 47 (13; 22–72) 51 (16; 19–83)
  Male sex, n (%) 7 (25.9) 15 (51.7) 32 (46.3) 10 (47.6) 26 (46.4) 77 (44.2) 35 (38.8) 202 (43.3)
Vascular risk factors
  Hypertension, n (%) 9 (33.3) 2 (6.8) 12 (17.3) 4 (19) 17 (30.3) 34 (19.5) 21 (23.3) 99 (21.2)
  Hypercholesterolemia, 
n (%)
7 (25.9) 3 (10.3) 48 (69.5) 6 (35.3) 28 (50) 76 (43.6) 24 (26.6) 192 (41.2)
  Diabetes mellitus, n (%) 2 (7.4) 1 (3.4) 0 (0) 0 (0) 4 (7.1) 4 (2.2) 2 (2.2) 13 (2.7)
  Smoking, pack-years 
(median; IQR; range)
12.6 (10; 8–72) 1 (1; 0–1) 0.5 (10; 0–64) 0 (0; 0–250) 0 (0; 0–720) 20 (21.75; 2–60) 17 (13.7; 2–75) 1 (13.8; 0–720)
  nWMHV, % (median; 
IQR; range)
2.2 (5.85;  
0–11.17)
5.85 (5.05;  
0–12.85)
3.9 (4.65;  
0–14.72)
4.8 (3.82;  
0–14.82)
3.51 (4.26;  
0.03–14.97)
5.7 (6.94;  
0.07–21.93)
6.45 (8.01;  
0.05–24.27)
5.24 (6.4;  
0–24.27)
CADASIL indicates cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy; IQR, interquartile range; and nWMHV, normalized 
white matter hyperintensity volume.
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hypertension. GCTA analysis resulted in a heritability estimate 
of 0.85 (SE=0.21) explained by common SNPs in cluster 1.
No SNP reached the genome-wide significance level of 
P<5×10–8. Six SNPs showed association with P<1×10–5 (Table 
in the online-only Data Supplement). However, there was no 
association with variants at the previously reported locus for 
WMH burden on chr17q25 (Figure 3). rs7218738, the SNP 
with the lowest P value (P=0.27) in this region defined as 
±50 kb around the lead SNP, is in low linkage disequilib-
rium (r2=0.275) with rs3744028, the lead SNP in the Cohorts 
for Heart and Aging Research in Genomic Epidemiology 
(CHARGE) study.9
Because of the high heritability estimate, we investigated 
whether a polygenic score could be created for the associa-
tion with WMH. Applying different thresholds of statisti-
cal significance, a polygenic score composed of all SNPs 
with a P value <0.5 in the derivation sample (cluster 1) 
was associated with WMH volume in the validation sample 
(cluster 2) after correction for age, sex, and hypertension 
(P=0.001; Table 2).
Discussion
Our results demonstrate a substantial role for genetic modi-
fiers of WMH burden in patients with CADASIL. Because 
the genome-wide platform we used examines only common 
variants and could not evaluate mutations in NOTCH3, we 
can be confident that the sequence variants responsible for 
WMH burden are novel. Our finding that a polygenic risk 
score predicts WMH burden points to the presence of particu-
lar variants for further study, but cannot single out any one 
gene or gene region. The heritability estimate derived from 
genotype data was remarkably high and close to conventional 
estimates obtained in CADASIL,12 normal elderly subjects,5,6 
and hypertensive sibships,3 suggesting that continuing the 
search for individual sequence variants underlying WMH in 
both CADASIL and sporadic WMH is likely to prove fruitful.
Our findings suggest that multiple common variants with 
very small effect sizes, rather than single variants with mod-
erate effect sizes, modify WMH burden in CADASIL. With 
466 subjects in our analysis, we had 90% power to detect an 
association at a genome-wide level (P<5×10–8) for a variant 
explaining 8.67% of variance of WMH volume assuming addi-
tive effects. Depending on minor allele frequency, this would 
correspond to an increase of 2.1% to 4.7% in normalized 
WMH volume per allele. We, therefore, think that any strong 
signals related to common variants would have been picked up 
by our approach. However, it should be noted that our genotyp-
ing protocol did not cover rare variants, which may likewise 
contribute to quantitative traits.19 Thus, it is possible that some 
of the heritability of WMH volume in CADASIL is due to rare 
variants. Of note, there was no indication for a disease-modify-
ing influence of common or rare variants at the NOTCH3 locus 
(Figure 3; data not shown). Future studies with full sequencing 
of the NOTCH3 locus will further address this question.
The absence of signals of moderate to strong effect that reach 
genome-wide significance is broadly consistent with findings 
from a GWAS in 9361 stroke-free individuals from the general 
population, which found no variants to be significantly associ-
ated with WMH burden except for a single locus on chromo-
some 17q25,9 which was recently replicated in stroke patients.10 
In the current study, we found no association signal with vari-
ants at 17q25. This might relate to differences in the protocols 
used for measuring WMH burden or to a differential impact of 
17q25 region on WMH burden in normal elderly subjects and 
CADASIL. In fact, previous studies have demonstrated slight 
differences in the distribution of WMH in CADASIL and spo-
radic disease,20 indicating that the mechanisms might partially 
differ. Further studies are needed to address this question.
Heritability, as estimated in our study, is unexpectedly high 
but largely consistent with previous measurements obtained 
without genome-wide genotyping.12 Cryptic relatedness 
and lack of power might have led to some overestimation. 
Table 2. Association of Polygenic Scores With White Matter 
Hyperintensity Volume
P Value Threshold 
(Derivation Sample) Number of SNPs*
P Value  
(Validation Sample)
Adjusted 
R 2
1e−4 14 0.32 0.41
0.001 105 0.88 0.41
0.01 1035 0.28 0.41
0.1 10 574 0.001 0.46
0.5 52 125 0.001 0.46
*Linkage disequilibrium–pruned single nucleotide polymorphisms (SNPs); 
R 2 describes the variance explained by the full model (polygenic score plus 
covariates); R 2 for the reduced model (covariates only) was 0.41. Note that 
increasing P thresholds in the derivation sample leads to an increase in statistical 
significance and variance explained in the validation sample. After additional 
correction for 20 principal components, association of the polygenic score at 
P=0.5 in the derivation sample remained statistically significant (P=0.02).
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Figure 3. Genome-wide association results for 
white matter hyperintensity burden in cerebral 
autosomal-dominant arteriopathy with subcortical 
infarcts and leukoencephalopathy. Meta-analysis P 
values are plotted against their genomic position.
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Nevertheless, in conjunction with our findings on polygenic 
score, this adds to the notion that white matter integrity is 
strongly influenced by genetic variation. A recent study in 
individuals at high risk of mood disorders found a polygenic 
score for major depressive disorder to be significantly asso-
ciated with reduced fractional anisotropy, an index of white 
matter integrity.21 Diffusion tensor imaging parameters, such 
as fractional anisotropy, capture subtle alterations in the white 
and grey matter not visible on conventional scans. They may 
thus be considered complementary to the quantification of 
WMH volume. Future large-scale genetic studies will have to 
determine whether genetic variants impacting on WMH vol-
umes and diffusion tensor imaging metrics overlap.
Specific strengths of this study include the unique sample 
of patients with pure SVD covering a broad range of WMH 
volumes, centralized image analysis with volumetric WMH 
measurements using validated protocols, and the inclusion of 
known risk factors for WMH into the models. The main lim-
itations include small sample size and the fact that the data 
originated from different MR scanners. Also, we did not assess 
lacunar lesion volume, another quantitative marker of SVD. 
However, differentiating lacunes from other imaging findings, 
such as dilated Virchow–Robin spaces, may be difficult,22 and a 
recent study in patients with acute ischemic stroke showed that 
the signals for WMH and lacunes do not necessarily overlap.10
In conclusion, we found a polygenic risk score to be asso-
ciated with WMH volume in CADASIL. Our results suggest 
that multiple genetic variants with small effect sizes influence 
WMH burden. The identification of causative genetic variants 
is likely to shed light on the pathophysiology of WMH forma-
tion in CADASIL and possibly in sporadic SVD as well.
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Supplementary figure: Illustration of genomic clusters. Clusters were formed by IBS-based 
principal component analysis to identify different genetic backgrounds. 
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 Supplementary table: SNPs showing associations with p<10-4  in meta-analysis on clusters 
1 and 2. * indicates effect direction in cluster 1 (first digit) and cluster 2 (second digit); 
? indicates that the genotype is not available. 
 
SNP ID chromosome effect 
allele 
position beta p-value effects* 
       
rs12350534 9 T 89558064 0.044675 3.73e-06 ++ 
rs12542166 8 C 122982838 0.105585 5.69e-06 +? 
rs271674 17 T 47978986 0.026664 6.27e-06 ++ 
rs10491606 9 T 89472918 0.055971 8.33e-06 ?+ 
rs1014137 7 C 31623746 0.024063 8.44e-06 ++ 
rs10255684 7 T 153642578 -0.024154 9.51e-06 -- 
rs1006979 3 G 153376620 0.056043 1.16e-05 ?+ 
rs4988496 7 A 31008686 -0.053842 1.31e-05 -- 
rs7773966 6 T 112231970 0.031887 1.45e-05 ++ 
rs16999508 21 T 25489609 0.049134 1.47e-05 ++ 
rs8035572 15 C 59891498 0.027495 1.64e-05 ++ 
rs2058280 7 G 31657634 0.022316 2.33e-05 ++ 
rs38379 7 T 31672870 -0.02392 2.36e-05 -- 
rs217070 11 C 88067394 0.04344 2.54e-05 ?+ 
rs13297620 9 G 78958032 -0.070244 2.72e-05 -- 
rs1159351 8 A 18169275 0.02414 2.78e-05 ++ 
rs1116163 12 G 30927650 -0.029084 2.85e-05 -- 
rs10488710 11 C 115207176 0.023265 3.05e-05 ++ 
rs7773297 6 T 45961770 0.022228 3.42e-05 ++ 
rs7772905 6 T 45961515 0.022058 3.63e-05 ++ 
rs16947095 16 A 78115623 -0.022052 3.74e-05 -- 
rs11770635 7 T 75794560 0.026487 3.91e-05 ++ 
rs10494300 1 C 154726546 0.021861 4.16e-05 ++ 
rs11051070 12 C 30925894 -0.028196 4.24e-05 -- 
rs11641213 16 G 78115195 -0.021988 4.45e-05 -- 
rs9371399 6 G 156177293 -0.024464 4.47e-05 -- 
rs533173 6 T 143115760 -0.023848 4.48e-05 -- 
rs7029464 9 T 118587823 0.039982 4.67e-05 +? 
rs2109395 7 G 31646038 0.021811 4.85e-05 ++ 
rs11649069 16 T 78140002 -0.022566 5e-05 -- 
rs879800 13 T 74377445 0.034692 5.18e-05 ++ 
rs217061 11 T 88060200 0.027328 5.29e-05 ++ 
rs1922617 16 A 78112263 -0.02157 5.3e-05 -- 
rs7623768 3 C 33182052 0.027601 5.36e-05 ++ 
rs7184534 16 C 79882250 -0.065647 5.53e-05 ?- 
rs17232143 10 A 131926442 -0.032217 5.63e-05 -- 
rs38332 7 A 31652328 0.022933 5.77e-05 ++ 
rs1431500 3 C 197191912 -0.022639 5.82e-05 -- 
rs291005 9 T 93540345 -0.02727 5.88e-05 -- 
rs289123 15 G 62639641 -0.028398 5.99e-05 ?- 
rs10245531 7 C 75822876 0.025346 6.03e-05 ++ 
rs10062532 5 A 61164989 0.029253 6.2e-05 ++ 
rs10788067 10 G 122095519 0.023475 6.69e-05 ++ 
rs2420698 10 C 122095184 0.023285 7.43e-05 ++ 
rs7937152 11 T 131936494 -0.021481 7.47e-05 -- 
rs10151617 14 G 98996159 0.027133 7.72e-05 ++ 
rs9457273 6 T 167520749 0.020817 7.92e-05 ++ 
rs10040815 5 G 19018089 -0.021229 8.05e-05 -- 
rs17642444 8 T 18172011 0.02305 8.07e-05 ++ 
rs2742989 6 T 19084034 -0.090617 8.14e-05 ?- 
rs12439364 15 C 22905631 -0.020675 8.22e-05 -- 
rs525928 6 T 143121577 -0.022888 8.27e-05 -- 
rs7020190 9 C 101086941 0.020129 8.34e-05 ++ 
rs491414 6 G 143115636 -0.023283 8.44e-05 -- 
rs1515264 2 A 147795431 0.046588 8.59e-05 ++ 
rs13387604 2 G 47184989 0.035146 9.01e-05 ++ 
rs9555795 13 T 112042272 0.025063 9.05e-05 ++ 
rs217059 11 G 88057255 0.026627 9.43e-05 ++ 
rs9372316 6 G 112203035 0.024674 9.72e-05 ++ 
rs4373389 6 T 112212449 0.024674 9.72e-05 ++ 
rs2026603 6 G 112215441 0.024674 9.72e-05 ++ 
rs12350534 9 T 89558064 0.044675 3.73e-06 ++ 
rs12542166 8 C 122982838 0.105585 5.69e-06 +? 
rs271674 17 T 47978986 0.026664 6.27e-06 ++ 
rs10491606 9 T 89472918 0.055971 8.33e-06 ?+ 
rs1014137 7 C 31623746 0.024063 8.44e-06 ++ 
rs10255684 7 T 153642578 -0.024154 9.51e-06 -- 
rs1006979 3 G 153376620 0.056043 1.16e-05 ?+ 
rs4988496 7 A 31008686 -0.053842 1.31e-05 -- 
rs7773966 6 T 112231970 0.031887 1.45e-05 ++ 
rs16999508 21 T 25489609 0.049134 1.47e-05 ++ 
rs8035572 15 C 59891498 0.027495 1.64e-05 ++ 
rs2058280 7 G 31657634 0.022316 2.33e-05 ++ 
rs38379 7 T 31672870 -0.02392 2.36e-05 -- 
rs217070 11 C 88067394 0.04344 2.54e-05 ?+ 
rs13297620 9 G 78958032 -0.070244 2.72e-05 -- 
rs1159351 8 A 18169275 0.02414 2.78e-05 ++ 
rs1116163 12 G 30927650 -0.029084 2.85e-05 -- 
rs10488710 11 C 115207176 0.023265 3.05e-05 ++ 
rs7773297 6 T 45961770 0.022228 3.42e-05 ++ 
rs7772905 6 T 45961515 0.022058 3.63e-05 ++ 
rs16947095 16 A 78115623 -0.022052 3.74e-05 -- 
rs11770635 7 T 75794560 0.026487 3.91e-05 ++ 
rs10494300 1 C 154726546 0.021861 4.16e-05 ++ 
rs11051070 12 C 30925894 -0.028196 4.24e-05 -- 
rs11641213 16 G 78115195 -0.021988 4.45e-05 -- 
rs9371399 6 G 156177293 -0.024464 4.47e-05 -- 
rs533173 6 T 143115760 -0.023848 4.48e-05 -- 
rs7029464 9 T 118587823 0.039982 4.67e-05 +? 
rs2109395 7 G 31646038 0.021811 4.85e-05 ++ 
rs11649069 16 T 78140002 -0.022566 5e-05 -- 
rs879800 13 T 74377445 0.034692 5.18e-05 ++ 
rs217061 11 T 88060200 0.027328 5.29e-05 ++ 
rs1922617 16 A 78112263 -0.02157 5.3e-05 -- 
rs7623768 3 C 33182052 0.027601 5.36e-05 ++ 
rs7184534 16 C 79882250 -0.065647 5.53e-05 ?- 
rs17232143 10 A 131926442 -0.032217 5.63e-05 -- 
rs38332 7 A 31652328 0.022933 5.77e-05 ++ 
rs1431500 3 C 197191912 -0.022639 5.82e-05 -- 
rs291005 9 T 93540345 -0.02727 5.88e-05 -- 
rs289123 15 G 62639641 -0.028398 5.99e-05 ?- 
rs10245531 7 C 75822876 0.025346 6.03e-05 ++ 
rs10062532 5 A 61164989 0.029253 6.2e-05 ++ 
rs10788067 10 G 122095519 0.023475 6.69e-05 ++ 
rs2420698 10 C 122095184 0.023285 7.43e-05 ++ 
rs7937152 11 T 131936494 -0.021481 7.47e-05 -- 
rs10151617 14 G 98996159 0.027133 7.72e-05 ++ 
rs9457273 6 T 167520749 0.020817 7.92e-05 ++ 
rs10040815 5 G 19018089 -0.021229 8.05e-05 -- 
rs17642444 8 T 18172011 0.02305 8.07e-05 ++ 
rs2742989 6 T 19084034 -0.090617 8.14e-05 ?- 
rs12439364 15 C 22905631 -0.020675 8.22e-05 -- 
rs525928 6 T 143121577 -0.022888 8.27e-05 -- 
rs7020190 9 C 101086941 0.020129 8.34e-05 ++ 
rs491414 6 G 143115636 -0.023283 8.44e-05 -- 
rs1515264 2 A 147795431 0.046588 8.59e-05 ++ 
rs13387604 2 G 47184989 0.035146 9.01e-05 ++ 
rs9555795 13 T 112042272 0.025063 9.05e-05 ++ 
rs217059 11 G 88057255 0.026627 9.43e-05 ++ 
rs9372316 6 G 112203035 0.024674 9.72e-05 ++ 
rs4373389 6 T 112212449 0.024674 9.72e-05 ++ 
rs2026603 6 G 112215441 0.024674 9.72e-05 ++ 
rs12350534 9 T 89558064 0.044675 3.73e-06 ++ 
rs12542166 8 C 122982838 0.105585 5.69e-06 +? 
rs271674 17 T 47978986 0.026664 6.27e-06 ++ 
rs10491606 9 T 89472918 0.055971 8.33e-06 ?+ 
rs1014137 7 C 31623746 0.024063 8.44e-06 ++ 
rs10255684 7 T 153642578 -0.024154 9.51e-06 -- 
rs1006979 3 G 153376620 0.056043 1.16e-05 ?+ 
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